3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Phase 3
1
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
18
Arthritis, Rheumatoid
4
Neoplasm, Residual
3
Meningeal Carcinomatosis
2
Burkitt Lymphoma
2
Subcutaneous panniculitis-like T-cell lymphoma
1
Psoriasis
1
Mycosis Fungoides
1
Medulloblastoma
1
Mediastinal Neoplasms
1
Lymphoma, T-Cell, Cutaneous
1
Lymphoma, Large-Cell, Anaplastic
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma
1
Leukemia, Biphenotypic, Acute
1
Immunoblastic Lymphadenopathy
1
Enteropathy-Associated T-Cell Lymphoma
1
Interventions
secukinumab
1
Methotrexate
1
Folic Acid
1
Etanercept
1
Adalimumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 4
×
Psoriasis
×
Methotrexate
×
Clear all
NCT00932113
2017-08-31
MOA
Tufts Medical Center
Phase 4
Completed
33 enrolled
11 charts